1. Home
  2. Our Services
  3. Securities
  4. Recent Transactions

 

Announcement Type Status Transaction Value
Jul 2019 Advisory Pending Financial advisor to Pfizer in connection with its separation of Up John and combination with Mylan Combined enterprise value of ~$47 billion
Jul 2019 Financing Closed Joint bookrunner to Mirum on its initial public offering $75 million
Jul 2019 Financing Closed Joint bookrunner to Ra Pharmaceuticals on its follow-on offering $149.5 million
Jul 2019 Financing Closed Lead manager to Avrobio on its confidentially marketed public offering $138 million
Jul 2019 Financing Closed Lead manager to Forty Seven on its confidentially marketed public offering $86 million
Jun 2019 Financing Closed Co-manager to Change Healthcare on its common stock offering $641 million
Jun 2019 Financing Closed Co-manager to Change Healthcare on its mandatory convertible preferred $288 million
Jun 2019 Financing Closed Joint bookrunner to Adaptive Biotechnologies on its initial public offering $345 million
Jun 2019 Advisory Pending Financial advisor to Barnes & Noble in connection with its sale to Elliott $683 million
Jun 2019 Advisory Pending Financial advisor to Novimmune in connection with its sale to Sobi ₣515 million


© 2019 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.